☆ 4.2 Article

Aberrant Expression of Thymosin Beta-4 Correlates With Advanced Disease and BRAF V600E Mutation in Thyroid Cancer

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2022)

Related references

Note: Only part of the references are listed.

Article Oncology

SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway

Chi-Yu Kuo et al.

Summary: Aberrant lipid metabolism plays a crucial role in providing energy, building materials, and oxidative stress resistance to cancer cells. This study found that high expression of SREBP1 in invasive thyroid cancer is associated with extrathyroidal extension, advanced disease stage, and shorter disease-specific survival. SREBP1 overexpression promotes cancer cell invasiveness through the upregulation of CYR61/CTGF via the Hippo-YAP pathway.

ENDOCRINE-RELATED CANCER (2022)

Add to Collection

Article Endocrinology & Metabolism

Thyroid Cancer Incidence and Mortality Trends in the United States: 2000-2018

Uchechukwu C. C. Megwalu et al.

Summary: Thyroid cancer incidence rates have declined since 2014, with similar declines noted for papillary thyroid carcinoma (PTC), localized disease, and tumors <= 1.0 cm, but not for tumors >2.0 cm. Incidence-based mortality rates continue to increase. These findings suggest changes in the management of thyroid nodules may have led to a decrease in the diagnosis of small indolent tumors, but not more advanced tumors.

THYROID (2022)

Add to Collection

Review Oncology

Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era

Jaume Capdevila et al.

Summary: Most malignant thyroid tumours are initially treated with surgery or a combination of surgery and radioactive iodine therapy. However, in patients with metastatic disease, many tumours become refractory to radioactive iodine (RAI), and these patients require alternative treatments, such as locoregional therapies and/or systemic treatment with multikinase inhibitors. Targeted therapies based on genetic alterations have shown clinical efficacy in thyroid cancer, including NTRK gene fusions, RET and BRAF inhibitions. Effective testing strategies for these genetic alterations are crucial for identifying patients who could benefit from targeted treatments.

CANCER TREATMENT REVIEWS (2022)

Add to Collection

Article Nutrition & Dietetics

Transcriptomic Characteristics Associated With Aging in the Thyroid Gland

Chien-Liang Liu et al.

Summary: This study analyzed RNA sequencing data of normal thyroid tissues and identified gene expression changes associated with aging. The findings shed light on molecular mechanisms underlying thyroid disorders in the geriatric population.

FRONTIERS IN NUTRITION (2022)

Add to Collection

Article Oncology

Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study

Brittany A. McKelvey et al.

Summary: This study focused on the role of TERT and BRAF copy number variations in papillary thyroid cancer (PTC), revealing that TERT amplifications are more common in later stage tumors and are frequently found in tumors with TERT mutations, while BRAF amplifications are more commonly associated with BRAF wildtype tumors and certain subtypes of PTC. Analyzing the differences in patterns of TERT and BRAF amplifications in relation to mutation status may contribute to a better understanding of cancer drivers in thyroid cancer.

GENES CHROMOSOMES & CANCER (2021)

Add to Collection

Article Multidisciplinary Sciences

Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma

Weilin Pu et al.

Summary: The study utilized single-cell RNA sequencing to comprehensively analyze the tumour microenvironment of PTC, identifying potential therapeutic strategies such as immunotherapy and anti-angiogenic therapy combination. The research discovered premalignant thyrocyte populations and different malignant thyrocyte phenotypes, offering insights into prognosis and treatment implications.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Endocrinology & Metabolism

Progress on the Function and Application of Thymosin β4

Yuan Xing et al.

Summary: Thymosin beta 4 (Tβ4) is a multifunctional peptide that plays a key role in physiological processes such as angiogenesis and proliferation, as well as inhibiting apoptosis and inflammation. It is effectively utilized in various indications and there is ongoing research on its potential applications and mechanisms.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Preoperative Factors Associated with Extrathyroidal Extension in Papillary Thyroid Cancer

Chi-Yu Kuo et al.

EUROPEAN THYROID JOURNAL (2020)

Add to Collection

Article Oncology

Lymphovascular invasion of papillary thyroid carcinoma revisited in the era of active surveillance

Shih-Ping Cheng et al.

EJSO (2020)

Add to Collection

Article Oncology

Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer

Shih-Ping Cheng et al.

JOURNAL OF PATHOLOGY (2020)

Add to Collection

Article Oncology

Tumor Progression is Mediated by Thymosin-β4 through a TGFβ/MRTF Signaling Axis

Tsuyoshi Morita et al.

MOLECULAR CANCER RESEARCH (2018)

Add to Collection

Article Multidisciplinary Sciences

Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma

Li-Hsing Chi et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Oncology

Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAFv600E

Amjad Husain et al.

CANCER LETTERS (2016)

Add to Collection

Review Medicine, Research & Experimental

Thymosin β as an Actin-binding Protein with a Variety of Functions

Aleksandra Kuzan

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2016)

Add to Collection

Article Biotechnology & Applied Microbiology

Comparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid

Hans-Juergen Schulten et al.

BMC GENOMICS (2015)

Add to Collection

Article Oncology

Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer

M. Tarabichi et al.

BRITISH JOURNAL OF CANCER (2015)

Add to Collection

Article Cell Biology

Expression of haem oxygenase-1 correlates with tumour aggressiveness and BRAFV600E expression in thyroid cancer

Tao-Yeuan Wang et al.

HISTOPATHOLOGY (2015)

Add to Collection

Article Oncology

Significance of Allelic Percentage of BRAF c.1799T > A (V600E) Mutation in Papillary Thyroid Carcinoma

Shih-Ping Cheng et al.

ANNALS OF SURGICAL ONCOLOGY (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal et al.

CELL (2014)

Add to Collection

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Thymosin β4 expression reveals intriguing similarities between fetal and cancer cells

Gavino Faa et al.

THYMOSINS IN HEALTH AND DISEASE I (2012)

Add to Collection

Article Immunology

Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors

Bilge Can et al.

APMIS (2012)

Add to Collection

Article Oncology

Thymosin β-4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial mesenchymal transition

Sonia Nemolato et al.

CANCER BIOLOGY & THERAPY (2012)

Add to Collection

Article Oncology

Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration

Yun-Kyoung Ryu et al.

INTERNATIONAL JOURNAL OF CANCER (2012)

Add to Collection

Article Biochemistry & Molecular Biology

A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic

G. Tomas et al.

ONCOGENE (2012)

Add to Collection

Article Biochemistry & Molecular Biology

Thymosin β4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase

H.-C. Huang et al.

ONCOGENE (2007)

Add to Collection

Article Multidisciplinary Sciences

Genomic analysis of metastasis reveals an essential role for RhoC

EA Clark et al.

NATURE (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.